Another imminent problem is that the GLP-1RAs that are currently used in the clinical setting are biological macromolecular peptide preparations, such as exenatide and liraglutide, with high production costs that limit their clinical application (231)
Until those studies are complete and the FDA reviews the data, it remains an experimental medication
Nat Med 22:8490
Opinions on GLP-1 regulation are mixed: 40% think the current rules are fair, 28% want fewer restrictions, and 22% think there should be more
Not to mention, decreased weight can allow us to be more active, a win-win for weight loss and health
My solution to this problem was simple: 1 shot of 2.5-5 mg of Tirzepatide weekly combined with 1 shot of Retatrutide at 2-4 mg weekly By leveraging the appetite-suppressing effects of Tirzepatide to eliminate cravings and hunger, I was able to get the best of both worlds simultaneously